Company Information
Industry 制造业
Company Introduction 公司主营业务为生物制药及中成药的研发、生产和销售,辅以房地产开发、物业管理和服务等业务。公司经过多年的产业布局和研发投入,医药产品覆盖创新基因工程制药、新型疫苗、现代中药等多个医药细分领域,是公司业绩的主要来源。房地产业务进行有计划的土地储备,立足特色地产开发与经营。
Main Business 生物制药及中成药的研发、生产和销售,辅以房地产开发、物业管理和服务等业务。
Legal Representative 马骥
Top Executives
董事长:马骥
董事:王志刚,姜云涛,祝先潮,张玉智,叶朋
独立董事:李春好,张春颖,张伟明
Top 5 Shareholder
Shareholder name Nature Holding Date
长春超达投资集团有限公司流通A股18.85%31/03/2024
王思勉流通A股7.42%31/03/2024
香港中央结算有限公司流通A股2.89%31/03/2024
林殿海流通A股1.81%31/03/2024
中央汇金资产管理有限责任公司流通A股1.59%31/03/2024
Company Secretary 张德申
Solicitors 北京市康达律师事务所
Auditors 大信会计师事务所(特殊普通合伙);普华永道中天会计师事务所(特殊普通合伙)
Tel No 0431-80557027
Fax No 0431-80557027
Website ccht.jl.cn
Email 000661@ccht.jl.cn;zds@ccht.jl.cn
Company Address
Register: 吉林省长春海容酒店及海茵广场写字楼B座2708室
Office: 吉林省长春市高新海容广场B座27层(震宇街与东蔚山路交汇)
Listing Date 18/12/1996
Shares Capital
Shares Capital: 404,423,090
Total A Share: 404,423,090
Listed A Share: 401,940,440
Non-tradable A Share: 2,482,650
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 11.210
DPS(RMB)* ¥ 4.500
NBV Per Share(RMB)* ¥ 54.552
Market Capitalization(RMB) 46.352B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.